Skip to main content

Articles

Page 2 of 72

  1. Our objective was to describe differences among adolescents and young adults (AYAs) with rheumatic disease using teratogens compared to non-users in receipt of sexual and reproductive health (SRH) counseling, ...

    Authors: Brittany Huynh, Mary A. Ott and Stacey E. Tarvin
    Citation: Pediatric Rheumatology 2025 23:5
  2. Childhood blindness significantly impacts development, education, employment, and mental health, creating burden for families and society. Between 8% and 30% of children with Juvenile Idiopathic Arthritis (JIA...

    Authors: Ameenat Lola Solebo and Ivan Foeldvari
    Citation: Pediatric Rheumatology 2025 23:4
  3. Depression adversely affects health outcomes in patients with childhood-onset systemic lupus erythematous (cSLE). By identifying patients with depressive symptoms, we can intervene early with referrals to ment...

    Authors: Emily Datyner, Jodi Dingle, Victoria Newsome, Lisa H. Buckley, Natasha Belsky, Seungweon Park, Manda Mitchell, Brooke Fine, Barron Patterson, T. Brent Graham and Alaina Davis
    Citation: Pediatric Rheumatology 2025 23:3
  4. NSAIDs are commonly used as first line therapy in chronic nonbacterial osteomyelitis (CNO) but are not effective for all patients. The objective of this study was to identify clinical variables associated with...

    Authors: Katherine D. Nowicki, Nathan D. Rogers, Carson L. Keeter, Nathan J. Donaldson, Jennifer B. Soep and Yongdong Zhao
    Citation: Pediatric Rheumatology 2025 23:2
  5. Pediatric patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) are at an increased risk of arterial and venous thromboembolism (AVTE). Although the exact mechanisms underlying AVTE remain unclear...

    Authors: Batuhan Küçükali, Merve Yazol, Çisem Yıldız, Büşra Acun, Nuran Belder, Nihal Karaçayır, Merve Kutlar, Pelin Esmeray Şenol, Zühre Kaya, Deniz Gezgin Yıldırım and Sevcan A. Bakkaloğlu
    Citation: Pediatric Rheumatology 2025 23:1
  6. Juvenile idiopathic arthritis (JIA) is challenging to classify and effectively monitor due to the lack of disease- and subtype-specific biomarkers. A robust molecular signature that tracks with specific JIA fe...

    Authors: Jooa Kwon, Melanie R. Neeland, Justine A. Ellis, Jane Munro, Richard Saffery, Boris Novakovic and Toby Mansell
    Citation: Pediatric Rheumatology 2024 22:113
  7. This systematic search and review aimed to evaluate the available literature on discontinuation of adalimumab and other tumor necrosis factor inhibitors (TNFi) for patients with well-controlled chronic inflamm...

    Authors: Erin Balay-Dustrude, Jessica Fennell, Kevin Baszis, Y. Ingrid Goh, Daniel B. Horton, Tzielan Lee, Chloe Rotman, Anna Sutton, Marinka Twilt and Olha Halyabar
    Citation: Pediatric Rheumatology 2024 22:112
  8. Primary small vessel CNS vasculitis (sv-cPACNS) is a challenging inflammatory brain disease in children. Brain biopsy is mandatory to confirm the diagnosis. This study aims to develop and validate a histologic...

    Authors: Maryam Nabavi Nouri, Anastasia Dropol, Pascal N. Tyrrell, Sheila Sheikh, Marinka Twilt, Jean Michaud, Benjamin Ellezam, Harvey B. Sarnat, Christopher Dunham, Peter W. Schutz, Julia Keith, David G. Munoz, Harry V. Vinters, Cynthia Hawkins and Susanne M. Benseler
    Citation: Pediatric Rheumatology 2024 22:111
  9. Aicardi-Goutières Syndrome is a monogenic type 1 interferonopathy with infantile onset, characterized by a variable degree of neurological damage. Approximately 7% of Aicardi-Goutières Syndrome cases are cause...

    Authors: Alba Gabaldon-Albero, Carla Martin-Grau, Miguel Marti-Masanet, Alejandro Lopez-Jimenez, Roberto Llorens, Beatriz Beseler-Soto, Sergio Martin-Zamora, Berta Lopez, Inmaculada Calvo, Sara Hernandez-Muela, Monica Rosello, Carmen Orellana and Francisco Martinez
    Citation: Pediatric Rheumatology 2024 22:110
  10. Juvenile Idiopathic Arthritis (JIA) is a chronic pediatric illness, whereby youth experience physical, emotional and psychosocial challenges that result in reduced health related quality of life (HRQL). Peer m...

    Authors: Fareha Nishat, Lauren Kelenc, Roberta Berard, Ciaran Duffy, Brian Feldman, Paula Forgeron, Adam M. Huber, Nadia Luca, Heinrike Schmeling, Lynn Spiegel, Lori Tucker, Karen Watanabe-Duffy, Tieghan Killackey, Chitra Lalloo, Brittany Wiles, Anya Nair…
    Citation: Pediatric Rheumatology 2024 22:109
  11. This study aims to develop Z-Score models to normalize measurements of three coronary arteries and enhance the diagnosis of Kawasaki disease (KD) in children from newborns to 10 years old. Developing a reliabl...

    Authors: Ho-Chang Kuo, Shih-Hsin Chen, I-Fei Chen, Wen-Ing Cheng, Shih-Feng Liu, Mindy Ming-Huey Guo, Yu-Chi Lin and Yi-Hui Chen
    Citation: Pediatric Rheumatology 2024 22:108
  12. The field of transitional care for chronic conditions in adolescents, notably juvenile idiopathic arthritis (JIA), is rapidly growing. Transitioning these patients to adult healthcare systems presents signific...

    Authors: Nihal Åžahin, Gülcan Özomay Baykal, Ceyhun Açarı, Pinar Özge Avar Aydın, Özge Baba, Esra BaÄŸlan, Sevcan BakkaloÄŸlu, Sibel Bakırcı, Yelda Bilginer, Burcu Yücel Bozkaya, Åžengül ÇaÄŸlayan, Mustafa Çakan, Figen Çakmak, Taner CoÅŸkuner, Ferhat Demir, Fatma Gül Demirkan…
    Citation: Pediatric Rheumatology 2024 22:105
  13. Most patients with a pediatric rheumatic disease are at increased risk of influenza due to immunosuppressive medication use. Despite initial quality improvement efforts, our influenza vaccination rate plateaue...

    Authors: Julia G. Harris, Leslie Favier, Jordan T. Jones, Maria Ibarra, Michael J. Holland, Emily Fox, Kelly Jensen, Ashley K. Sherman and Ashley M. Cooper
    Citation: Pediatric Rheumatology 2024 22:104
  14. To assess the psychosocial impact of moderate-severe juvenile idiopathic arthritis (JIA) on patients and their families, among those who had been treated with at least one anti-tumor necrosis factor (anti-TNF-...

    Authors: Inmaculada Calvo Penadés, Estefania Moreno Ruzafa, Joan Calzada-Hernández, Juan Mosquera Angarita, Berta López Montesinos, Rosa Bou, Mireia López Corbeto, Judith Sánchez-Manubens, María Isabel González Fernández, Sonia Carriquí Arenas, Violeta Bittermann, Carolina Estepa Guillén, Lucía Rodríguez Díez, Estíbaliz Iglesias, Miguel Marti Masanet, Lucía LaCruz Pérez…
    Citation: Pediatric Rheumatology 2024 22:102
  15. With increasing focus on patient-reported outcome measures (PROMs) in chronic rheumatic diseases, we aimed to evaluate the self-reported physical and psychosocial health in children with juvenile idiopathic ar...

    Authors: Sofie Mikalsen Arneng, Isabelle Pignatel Jenssen, Anette Lundestad, Lena Cetrelli, Oskar Angenete, Ellen Nordal, Karin B. Tylleskär, Pål Richard Romundstad and Marite Rygg
    Citation: Pediatric Rheumatology 2024 22:100
  16. Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation that results in an uncontrolled hyperinflammatory state. HLH is classified into two main categories: primary (familial) HLH and...

    Authors: Krit Cheawcharnpraparn, Thiraporn Kanjanaphan, Oranooj Lertkovit, Napaporn Puripat, Chutima Chavanisakun, Ornatcha Sirimongkolchaiyakul and Sirikarn Tangcheewinsirikul
    Citation: Pediatric Rheumatology 2024 22:98
  17. Authors: Daniel Windschall, Ralf Trauzeddel, Faekah Gohar, Hatice Adiguzel-Dundar, Sven Hardt, Manuela Krumrey-Langkammerer, Lampros Fotis, Rainer Berendes, Sebastian Schua, Maria Haller, Ferhat Demir, Betul Sözeri and Silvia Magni-Manzoni
    Citation: Pediatric Rheumatology 2024 22:97

    The original article was published in Pediatric Rheumatology 2024 22:94

  18. Interstitial lung disease (ILD) is a serious complication in systemic juvenile idiopathic arthritis (SJIA). This study aimed to identify the clinical characteristics and prognosis of SJIA-ILD.

    Authors: Wenting Zhan, Jinxiang Yang, Lingzhi Qiu, Kangkang Yang, Xiaohua Ye, Yaoyao Shangguan, Haiguo Yu and Wenjie Zheng
    Citation: Pediatric Rheumatology 2024 22:96
  19. Methotrexate (MTX) intolerance in juvenile idiopathic arthritis (JIA) frequently leads to discontinuation due to anticipatory and associative gastrointestinal symptoms. Eye Movement Desensitization and Reproce...

    Authors: Lea Höfel, Bruno Eppler, Johannes-Peter Haas and Boris Hügle
    Citation: Pediatric Rheumatology 2024 22:95
  20. To identify an optimal pediatric musculoskeletal ultrasound (MSUS) protocol for the detection of knee arthritis in patients with juvenile idiopathic arthritis (JIA) including a comparison with existing protoco...

    Authors: Daniel Windschall, Ralf Trauzeddel, Faekah Gohar, Hatice Adiguzel-Dundar, Sven Hardt, Manuela Krumrey-Langkammerer, Lampros Fotis, Rainer Berendes, Sebastian Schua, Maria Haller, Ferhat Demir, Betul Sözeri and Silvia Magni-Manzoni
    Citation: Pediatric Rheumatology 2024 22:94

    The Correction to this article has been published in Pediatric Rheumatology 2024 22:97

  21. Regular physical activity (PA) has been proven to help prevent non-communicable diseases and is beneficial for disease management in chronically ill populations. Physical inactivity and recreational screen-bas...

    Authors: Florian Milatz, Malthe Jessen Pedersen, Jens Klotsche, Ina Liedmann, Martina Niewerth, Anton Hospach, Gerd Horneff, Ariane Klein, Frank Weller-Heinemann, Ivan Foeldvari, Tilmann Kallinich, Johannes-Peter Haas, Daniel Windschall, Frank Dressler, Dirk Foell, Jasmin B. Kuemmerle-Deschner…
    Citation: Pediatric Rheumatology 2024 22:93
  22. There is no consensus or clinical guidelines for screening routines of autoimmune disease in individuals with juvenile idiopathic arthritis (JIA), since results are conflicting whether the risk for such condit...

    Authors: Alma Dahlberg, Helena Tydén, Anna Saxne Jöud, Fredrik Kahn and Elisabet Berthold
    Citation: Pediatric Rheumatology 2024 22:92
  23. The aim of the study was to evaluate the effectiveness of a novel e-learning module in teaching the physical exam of the temporomandibular joint (TMJ) in Juvenile idiopathic arthritis (JIA.).

    Authors: Nancy Pan, Rebecca E. Sadun, Melissa A. Lerman, Cory M. Resnick, James E. Bost, Peter Stoustrup, Marinka Twilt and Tova Ronis
    Citation: Pediatric Rheumatology 2024 22:91
  24. Gain of function (GOF) mutations in NOD-like receptor family CARD-containing 4 protein (NLRC4) gene induce a wide spectrum of autoinflammatory phenotypes. Currently, we categorize them into four groups: famili...

    Authors: Kosar Asna Ashari, Nima Parvaneh, Kayvan Mirnia, Mehri Ayati, Maryam Saeedi, Farhad Salehzadeh, Mohammad Shahrooei, Razieh Sangsari, Pejman Rohani and Vahid Ziaee
    Citation: Pediatric Rheumatology 2024 22:90
  25. Camurati-Engelmann disease (CED), also known as progressive diaphyseal dysplasia, is a rare genetic disorder characterized by abnormal thickening of the long bones’ diaphysis. This condition is caused by mutat...

    Authors: Ayşenur Alkaya, Adalet Elçin Yıldız, Esra Bağlan and Semanur Özdel
    Citation: Pediatric Rheumatology 2024 22:89
  26. Chronic anterior uveitis (CAU) carries a significant risk for eye complications and vision loss. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) introduced consensus treatment plans (CTPs) t...

    Authors: Margaret H. Chang, Fatima Barbar-Smiley, Shoghik Akoghlanian, Joanne Drew, Sheila T. Angeles-Han, Megan Quinlan-Waters, John F. Bohnsack, Ashley M. Cooper, Barbara Edelheit, Jennifer Twachtman-Bassett, Melissa A. Lerman, Kabita Nanda, C. Egla Rabinovich and Mindy S. Lo
    Citation: Pediatric Rheumatology 2024 22:88
  27. Cryopyrin-associated periodic syndrome (CAPS) is characterized by excessive IL-1β release resulting in systemic and organ inflammation. As an anti-IL-1 agent, canakinumab has been approved with all CAPS phenot...

    Authors: Xiaona Zhu, Jiaqi Fan, Yanyan Huang, Yongbin Xu, Zhi Yang, Ruohang Weng, Ying Luo, Jun Yang and Tingyan He
    Citation: Pediatric Rheumatology 2024 22:87
  28. Juvenile Dermatomyositis (JDM) is a rare disorder with subtypes associated with different myositis-specific antibodies (MSAs) including anti-MDA5. Hepatic involvement in JDM is rare and has not previously been...

    Authors: Mitchell Kinkor, Sameena Hameed, Alexander Kats, Voytek Slowik, Emily Fox and Maria Ibarra
    Citation: Pediatric Rheumatology 2024 22:86
  29. Protracted febrile myalgia syndrome (PFMS) is a rare manifestation of familial Mediterranean fever (FMF), characterized by myalgia, fever and elevated inflammatory markers lasting several weeks. As the hallmar...

    Authors: Toni Hospach, Friederike Blankenburg, Anita Heinkele, Thekla von Kalle, Yosef Uziel, Tillmann Kallinich and Kristina Rücklová
    Citation: Pediatric Rheumatology 2024 22:85
  30. The prevalence of back and neck pain is common in children and adolescents, and in some series the numbers are alarming. Various risk factors have been identified, although some are controversial.

    Authors: Alia Fazaa, Ines Cherif, Saoussen Miladi, Hiba boussaa, Yasmine makhlouf, Kaouther ben abdelghani and Ahmed laatar
    Citation: Pediatric Rheumatology 2024 22:84
  31. Osteoporosis is increasingly being recognized in children, mostly secondary to systemic underlying conditions or medication. However, no imaging modality currently provides a full evaluation of bone health in ...

    Authors: Thomas Augdal, Oskar Angenete, Pia Zadig, Anette Lundestad, Ellen Nordal, Xieqi Shi and Karen Rosendahl
    Citation: Pediatric Rheumatology 2024 22:80
  32. Juvenile Idiopathic Arthritis (JIA) is a complex autoimmune disease and the most common chronic rheumatological disease affecting children under the age of 16. The etiology of JIA remains poorly understood, bu...

    Authors: Raya Saleh, Erik Sundberg, Mia Olsson, Katarina Tengvall, Lars Alfredsson, Ingrid Kockum, Leonid Padyukov and Helena Erlandsson Harris
    Citation: Pediatric Rheumatology 2024 22:79
  33. Artificial intelligence (AI) has become a popular tool for clinical and research use in the medical field. The aim of this study was to evaluate the accuracy and reliability of a generative AI tool on pediatri...

    Authors: Saverio La Bella, Marina Attanasi, Annamaria Porreca, Armando Di Ludovico, Maria Cristina Maggio, Romina Gallizzi, Francesco La Torre, Donato Rigante, Francesca Soscia, Francesca Ardenti Morini, Antonella Insalaco, Marco Francesco Natale, Francesco Chiarelli, Gabriele Simonini, Fabrizio De Benedetti, Marco Gattorno…
    Citation: Pediatric Rheumatology 2024 22:78
  34. Current treatment for localized scleroderma (LS) has been shown to halt disease activity, but little is still known about patient experiences with these treatments, nor is there consensus about optimal measure...

    Authors: Alexy Hernandez, Leslie Zapata Leiva, Maria Mutka, Kathryn S. Torok, Leila Ledbetter and Christina K. Zigler
    Citation: Pediatric Rheumatology 2024 22:77
  35. This study aimed to develop a novel scoring system utilizing circulating interleukin (IL) levels to predict resistance to intravenous immunoglobulin (IVIG) in Chinese patients with Kawasaki disease (KD). We fu...

    Authors: Yuan-Yuan Zeng, Su-Yue Zhu, Kang-Kang Xu, Lian-Fu Ji, Yu-Qi Wang, Yi Chen, Feng Chen and Shi-Wei Yang
    Citation: Pediatric Rheumatology 2024 22:76
  36. Juvenile idiopathic arthritis (JIA) refers to a heterogeneous group of rheumatic conditions in children. Novel drugs have greatly improved disease outcomes; however, outcomes are impacted by limited awareness ...

    Authors: Deborah A. Marshall, Brittany Gerber, Gillian R. Currie, Jordi Antón, Lien De Somer, Michelle Dey, Tsipi Egert, Yona Egert, Lia Henan, Jens Klotsche, Laura Martinez Mifsut, Kirsten Minden, Christophe Normand, David Porte, Rotraud K. Saurenmann, Joost F. Swart…
    Citation: Pediatric Rheumatology 2024 22:74
  37. Juvenile dermatomyositis (JDM) is a systemic vasculopathy associated with metabolic derangements and possible increased risk for premature atherosclerosis. Oxidation of low-density lipoprotein (LDL) in the end...

    Authors: Jacob C. Spitznagle, Akadia Kacha-Ochana, Joan M. Cook-Mills, Gabrielle A. Morgan and Lauren M. Pachman
    Citation: Pediatric Rheumatology 2024 22:73
  38. Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can affect multiple organ systems and is heterogenous in its presentation and response to therapy. When diagnosed in childhood, SLE is ...

    Authors: Ivana Stojkic, Lauren Harper, Samantha Coss, Mahmoud Kallash, Kyla Driest, Margaret Lamb, Stacy P. Ardoin and Shoghik Akoghlanian
    Citation: Pediatric Rheumatology 2024 22:72
  39. Kawasaki Disease (KD) involves arterial inflammation, primarily affecting the coronary arteries and leading to coronary artery lesions. Recent advancements in understanding the immunomodulatory roles of vitami...

    Authors: Zahra Amirsardari, Fatemeh Amirsardari, Erfan Kohansal, Amir Ghaffari Jolfay, Maziar Gholampour Dehaki and Vahid Ziaee
    Citation: Pediatric Rheumatology 2024 22:71
  40. The interferon-gamma (IFN-γ) release assay (IGRA) is an important laboratory diagnosis for latent Mycobacterium tuberculosis (TB) infection. The TB-IGRA measures the release of IFN-γ from peripheral blood cells, ...

    Authors: Song Zhang, Xue Li, Huishan Chen, Xianfei Gao, Zhe Cai and Huasong Zeng
    Citation: Pediatric Rheumatology 2024 22:70
  41. To measure regulatory T cell (Treg) levels in the peripheral blood of children with juvenile idiopathic arthritis (JIA) and analyse the association of this measure with disease activity, quality of life, adjus...

    Authors: Neus Quilis, Pablo Mesa-del-Castillo Bermejo, Paula Boix, Oriol Juanola, Pilar Bernabeu, Rubén Francés and Mariano Andrés
    Citation: Pediatric Rheumatology 2024 22:69

Official journal of

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.8
    5-year Journal Impact Factor: 2.8
    Source Normalized Impact per Paper (SNIP): 0.966
    SCImago Journal Rank (SJR): 0.835

    Speed 2024
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 94

    Usage 2024
    Downloads: 1,320,783
    Altmetric mentions: 320